amakuru

Twishimiye kubamenyesha koKwinbon AmataGuard B + T Combo IkizamininaKwinbon AmataGuard BCCT Ikizaminibahawe impamyabumenyi ya ILVO ku ya 9 Kanama 2024!

BT 2024

Ikizamini cya MilkGuard B + T Combo Ikizamini ni amazi yo mu ntambwe ebyiri + 3 min yihuta yo gutembera kuruhande kugirango hamenyekane B-lactam na tetracyclines ibisigisigi bya antibiotique muri mikoro y'inka mbisi. Ikizamini gishingiye ku myitwarire yihariye ya antibody-antigen na immunochromatography. Antibiyotike ya B-lactam na tetracycline murugero irushanwa antibody hamwe na antigen yometse kuri membrane yikizamini.

Iki kizamini cyemejwe muri ILVO-T & V (Ikoranabuhanga & Ubumenyi bw’ibiribwa mu kigo cy’ubushakashatsi cya Flanders gishinzwe ubuhinzi, uburobyi n’ibiribwa) ukurikije tekiniki ya ISO 23758 | IDF RM 251 (ISO / IDF, 2021), Komisiyo Ishyira mu bikorwa Amabwiriza 2021/808 no ku nyandiko y'ubuyobozi bwa EURL ku buryo bwo gusuzuma uburyo bwo kwemeza (Anonymous, 2023). Ibipimo byisesengura bikurikira byagenzuwe: ubushobozi bwo gutahura, igipimo cyiza cyiza, gusubiramo ibizamini no gukomera. Ikizamini cyanashyizwe mubushakashatsi bwakozwe bwateguwe na ILVO mu mpeshyi 2024.

AmataGuard β-lactams & Cephalosporins & Ceftiofur & Tetracyclines Ikizamini cyo gupima ni intambwe ebyiri zujuje ibyiciro 3 + 7 min byihuta byihuta kugirango hamenyekane β-lactam, harimo cephalosporine, ceftiofur na tetracycline ibisigisigi bya antibiotique mu nka zinka zitangiye. Ikizamini gishingiye ku myitwarire yihariye ya antibody-antigen na immunochromatography. act-lactams, cephalosporine na tetracyclines antibiotique murugero rwipiganwa birwanya antibody hamwe na antigen yometse kumurongo wibizamini.

 

Kwinbon Rapid Ikizamini cyibizamini bifite ibyiza byihariye, sensibilité yo hejuru, imikorere yoroshye, ibisubizo byihuse, ituze ryinshi nubushobozi bukomeye bwo kurwanya kwivanga. Izi nyungu zituma ibizamini byipimisha bifite uburyo butandukanye bwo gusaba kandi bifite akamaro gakomeye mubijyanye no gupima ibiribwa.

BCCT 2024

Igihe cyo kohereza: Kanama-13-2024